Angioleiomyoma: An Update with a 142-Case Series
Life · 04.03.2024 · 14 (3) · 338
DOI: 10.3390/life14030338 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life, online erschienen am 04.03.2024. Verfasst von Mathilde Bernard und 3 weiteren Autor:innen. Beteiligte Einrichtung: Service de Chirurgie Orthopédique et Traumatologique, CHRU Trousseau, Faculté de Médecine de Tours, Université de Tours, 1C Avenue de la République, …. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Angioleiomyomas are uncommon, noncancerous, smooth muscle tumors that primarily arise from blood vessels. Previous studies have yielded limited data due to the lack of interdisciplinary approaches or restricted patient pools. This study aims to provide a comprehensive analysis of angioleiomyomas, including the demographic, clinical, radiological, and histopathological features, with a large number of patients. Conducted as a retrospective investigation at a single center from January 2005 to June 2023, this study involved 142 patients. Relevant information was extracted from electronic medical records, covering clinical, radiological, histological, and demographic details. Angioleiomyomas mostly occurred at age 59 (1–87), predominately affect females (53%) and commonly arise in subcutaneous tissue (85%) and the lower limbs (76%). MRI findings revealed characteristic signals, with a high prevalence of the solid histologic type (65%), often displaying a reticular sign. Smooth muscle Actin was universally present (n = 95/95), while Desmin and Caldesmon showed positive expression in 83% (n = 71/85) and 98% (n = 92/94) of cases, respectively. This study presents an updated and comprehensive analysis of angioleiomyomas. Typically appearing as well-defined nodules in the extremities, these tumors can be effectively diagnosed using MRI, though histopathological analysis is generally essential for confirmation. Treatment primarily involves straightforward excision, with notable low complication and recurrence rates.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Service de Chirurgie Orthopédique et Traumatologique, CHRU Trousseau, Faculté de Médecine de Tours, Université de Tours, 1C Avenue de la République, 37170 Chambray-les-Tours, France.
- CNRS ERL 7001 LNOx: Leukemic Niche & redOx Métabolisme, EA 7501 GICC, Université de Tours, 37000 Tours, France.
- Service d'Anatomie et Cytologie Pathologique, CHRU Trousseau, Faculté de Médecine de Tours, Université de Tours, 1C Avenue de la République, 37170 Chambray-les-Tours, France.
- Department of Orthopedic Surgery, Faculty of Medicine, University of Jeddah, Jeddah 23218, Saudi Arabia.
ORCID-Profile: Ramy Samargandi
Zitieren
APA
Bernard, M., Le Nail, L. R., de Pinieux, G., & Samargandi, R. (2024). Angioleiomyoma: An Update with a 142-Case Series. Life, 14(3), 338. https://doi.org/10.3390/life14030338
Vancouver
Bernard M, Le Nail LR, de Pinieux G, Samargandi R. Angioleiomyoma: An Update with a 142-Case Series. Life. 2024;14(3):338. doi:10.3390/life14030338
BibTeX
@article{Bernard2024,
author = {Bernard, Mathilde and Le Nail, Louis-Romée and de Pinieux, Gonzague and Samargandi, Ramy},
title = {Angioleiomyoma: An Update with a 142-Case Series},
journal = {Life},
year = {2024},
volume = {14},
number = {3},
pages = {338},
doi = {10.3390/life14030338}
}
EUVIMED